Provided by Tiger Trade Technology Pte. Ltd.

ResMed

231.52
+3.081.35%
Post-market: 231.520.00000.00%19:30 EDT
Volume:1.73M
Turnover:399.65M
Market Cap:33.40B
PE:22.20
High:234.14
Open:229.44
Low:228.54
Close:228.44
52wk High:293.81
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.34
T/O Rate:1.20%
Dividend:2.40
Dividend Rate:1.04%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.07
PE(LYR):22.20

Loading ...

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Yesterday

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

ResMed’s New OSA Diagnostic Study Signals Next Wave in Home Sleep Testing

TIPRANKS
·
Aug 20

Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

ResMed Initiated at Neutral by Rothschild & Co

Dow Jones
·
Aug 19

Rothschild & Co Redburn Initiates ResMed at Neutral With $230 Price Target

MT Newswires Live
·
Aug 19

ResMed initiated with a Neutral at Rothschild & Co Redburn

TIPRANKS
·
Aug 19

ResMed management to meet with KeyBanc

TIPRANKS
·
Aug 19

Details of Auditor Appointment/Resignation-RMD.N

Reuters
·
Aug 18

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 18

ResMed Names Carol Burt Lead Director as Ron Taylor Steps Down

Reuters
·
Aug 18

Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor

THOMSON REUTERS
·
Aug 18

Press Release: Sonata Software Appoints Hariprasad Rebala as Chief AI Officer

Dow Jones
·
Aug 17

ResMed Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 15

ResMed Confirms Status as Large Accelerated Filer in 2026 Form 10-K

TIPRANKS
·
Aug 14

How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds

Simply Wall St.
·
Aug 13

ResMed (RMD) Faces A 10% Fair Value Gap As Dividend Rises 10%

Simply Wall St.
·
Aug 12

Resmed Inc.-Statement of Changes in Beneficial Ownership

THOMSON REUTERS
·
Aug 12

Statement of Changes in Beneficial Ownership-RMD.N

Reuters
·
Aug 12

ResMed CEO Michael J. Farrell Reports Disposal of 4,991 Common Shares Worth $1,026,594.05

Reuters
·
Aug 11